Health Once-Weekly Efsitora Outperforms Daily Glargine in Diabetes Trial A recent clinical trial has revealed that Eli Lilly’s once-weekly insulin, efsitoria, offers comparable glycemic control to the traditional daily insulin glargine for patients... Editorial14 July, 2025